Select Medical Holdings Corp SEM R2K
Company Overview
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, pelvic health rehabilitation, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.
Why Investors Should Care
Trades at a P/E of 15.4, below the sector median of 25.4.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $5.45B (+5.1% YoY); net profit $146.22M.
- Trailing 12 Months Year-on-year growth — revenue +5.0%, earnings -19.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 5.8%, profit CAGR -2.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 5.76% |
| 1 Year: | 5.00% |
Compounded Profit Growth
| 5 Years: | -2.75% |
| 1 Year: | -19.40% |
Stock Price Performance
| 1 Year: | - |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | - |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
P/E of 15.43 is below the sector median of 25.41 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- Earnings shrank at -2.8% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SEM Select Medical Holdings Corp R2K | 16.51 | 15.43 | $2.05B | 0.02% | 6.91% | 9.81% | 5.76% | -2.75% |
| 2 | LLY Eli Lilly and Company SPX | 1,152.54 | 41.02 | $1.03T | 0.61% | - | 107.46% | 7.20% | 11.41% |
| 3 | JNJ Johnson & Johnson SPX | 253.85 | 29.45 | $611.07B | 2.23% | 14.88% | 26.42% | 2.43% | 4.76% |
| 4 | ABBV AbbVie Inc. SPX | 244.78 | 119.40 | $432.48B | 3.04% | 10.47% | -129.24% | 1.75% | -29.06% |
| 5 | UNH UnitedHealth Group Incorporated SPX | 425.19 | 32.02 | $386.13B | 2.27% | 9.74% | 12.18% | 10.40% | 5.43% |
| 6 | MRK Merck & Co., Inc. SPX | 120.78 | 34.02 | $298.31B | 2.86% | - | 18.94% | 5.64% | 10.01% |
| 7 | AZN AstraZeneca PLC NDX | 164.50 | 24.81 | $255.12B | 1.77% | 15.97% | 23.48% | 9.82% | 45.96% |
| 8 | TMO Thermo Fisher Scientific Inc. SPX | 534.07 | 29.33 | $198.47B | 0.40% | 8.14% | 13.52% | 8.81% | 12.95% |
| 9 | AMGN Amgen Inc. NDXSPX | 355.25 | 24.69 | $191.73B | 2.84% | 18.02% | 101.32% | 11.77% | 5.58% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 1.09B | 1.10B | 1.08B | 1.09B | 1.25B | 1.30B | 1.27B | 1.26B | 1.32B | 1.36B | 1.39B | 1.37B | 1.41B | 1.23B | 1.42B | 1.46B | 1.55B | 1.56B | 1.53B | 1.60B | 1.58B | 1.57B | 1.21B | 1.21B | 1.19B | 1.22B | 1.32B | 1.28B | 1.27B | - | 1.35B | 1.34B | 1.36B | 1.40B | 1.42B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.17B | 1.18B | 1.22B | 1.25B | 1.25B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 180.56M | 155.45M | 147.45M | 145.83M | 175.47M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 67.82M | 68.92M | 74.49M | 81.90M | 77.05M |
| Operating Income | 62.30M | 86.89M | 101.05M | 56.16M | 55.74M | 91.77M | 115.66M | 72.10M | 76.35M | 108.60M | 120.56M | 99.84M | 88.28M | 111.72M | 124.88M | 122.91M | 112.37M | 128.68M | 119.52M | 156.13M | 163.33M | 202.01M | 283.97M | 150.25M | 103.98M | 120.97M | 91.47M | 151.46M | 159.20M | 129.96M | - | 118.47M | 73.86M | 54.90M | - | 112.75M | 86.53M | 72.96M | 63.94M | 98.42M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 160.06M | 135.00M | 120.39M | 115.54M | 148.09M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 29.07M | 29.98M | 30.02M | 28.87M | 28.34M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 96.19M | 70.17M | 55.93M | 50.46M | 82.09M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 21.45M | 12.29M | 11.75M | 12.72M | 18.32M |
| Net Income | 29.33M | 54.83M | 33.94M | 6.47M | 20.17M | 15.87M | 42.05M | 18.46M | 100.80M | 33.74M | 46.51M | 32.92M | 24.67M | 40.83M | 44.82M | 30.73M | 32.07M | 53.12M | 51.65M | 76.95M | 77.27M | 110.55M | 164.89M | 76.93M | 49.12M | 55.21M | 27.17M | 70.81M | 78.24M | 48.18M | 46.27M | 96.90M | 77.56M | 55.63M | - | 56.68M | 40.57M | 28.79M | 20.17M | 43.99M |
| Diluted EPS | 0.22 | 0.42 | 0.26 | 0.05 | 0.15 | 0.12 | 0.32 | 0.14 | 0.75 | 0.25 | 0.35 | 0.24 | 0.18 | 0.30 | 0.33 | 0.23 | 0.24 | 0.40 | 0.39 | 0.57 | 0.57 | 0.82 | 1.22 | 0.57 | 0.37 | 0.43 | 0.21 | 0.56 | 0.61 | 0.38 | - | 0.75 | 0.60 | 0.43 | - | 0.44 | 0.32 | 0.23 | 0.16 | 0.35 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 4.22B | 4.37B | 5.08B | 5.45B | 5.53B | - | 4.61B | 4.83B | 5.19B | 5.45B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.21B | 4.25B | 4.55B | 4.82B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | 401.49M | 571.61M | 633.64M | 629.29M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 256.74M | 304.37M | 365.33M | 293.12M |
| Operating Income | 235.84M | 236.14M | 310.72M | 336.86M | 301.44M | 284.48M | 274.79M | 299.85M | 355.88M | 417.28M | 471.88M | 567.66M | - | 144.75M | 267.24M | 268.31M | 336.17M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | 378.56M | 502.63M | 507.27M | 530.99M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | 137.47M | 154.16M | 128.60M | 117.94M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | 35.27M | 139.72M | 174.77M | 272.75M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | 16.72M | 29.25M | 44.78M | 58.22M |
| Net Income | 75.28M | 77.64M | 107.85M | 148.23M | 114.39M | 120.63M | 130.74M | 115.41M | 177.18M | 137.84M | 148.45M | 259.00M | - | 158.99M | 243.49M | 214.04M | 146.22M |
| Diluted EPS | 0.61 | 0.48 | 0.71 | 1.05 | 0.82 | 0.91 | 0.99 | 0.87 | 1.33 | 1.02 | 1.10 | 1.93 | - | 1.23 | 1.91 | 1.66 | 1.16 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 2.72B | 2.77B | 2.76B | 2.82B | 2.92B | 4.39B | 4.92B | 5.13B | 5.96B | 7.34B | 7.66B | - | 7.67B | 7.69B | 5.61B | 5.85B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.27B | 1.26B | 1.02B | 1.03B |
| Cash & Equivalents | 64.26M | 83.68M | 4.37M | 12.04M | 40.14M | 4.32M | 3.35M | 14.44M | 99.03M | 122.55M | 175.18M | 335.88M | 577.06M | - | 97.91M | 52.63M | 59.69M | 26.52M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 941.31M | 724.14M | 821.38M | 864.21M |
| Total Liabilities | - | - | 1.91B | 1.92B | 2.01B | 1.99B | 2.14B | 3.24B | 3.59B | 3.55B | 4.27B | 5.44B | 6.00B | - | 6.27B | 6.12B | 3.61B | 3.82B |
| Current Liabilities | - | - | 499.56M | 383.94M | 373.27M | 371.52M | 394.42M | 729.28M | 571.63M | 605.40M | 705.19M | 914.28M | 1.44B | - | 1.16B | 1.25B | 977.65M | 984.49M |
| Long Term Debt | - | - | 1.28B | 1.39B | 1.46B | 1.43B | 1.54B | - | 2.70B | 2.70B | 3.29B | 3.45B | - | - | 3.84B | 3.58B | 1.69B | 1.80B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.16B | 4.52B | 2.70B | 2.87B |
| Total Equity | -166.40M | 760.30M | 783.88M | 819.68M | 717.05M | 786.23M | 739.51M | 859.25M | 815.73M | 823.37M | 803.04M | 770.97M | 1.06B | - | 1.12B | 1.29B | 1.68B | 1.71B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 127.17M | 128.37M | 128.96M | 124.02M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 165.64M | 144.54M | 217.13M | - | - | - | 208.41M | 346.60M | 238.13M | 494.19M | 445.18M | 1.03B | - | 284.82M | 582.06M | 517.86M | 346.47M |
| Investing Cash Flow | -77.92M | -217.00M | -54.73M | - | - | - | -1.21B | -554.32M | -192.97M | -697.14M | -316.73M | -115.35M | - | -226.34M | -268.48M | -231.01M | -216.49M |
| Financing Cash Flow | -68.30M | -6.85M | -154.72M | - | - | - | 1.01B | 292.31M | -21.65M | 255.57M | 32.25M | -671.54M | - | -34.89M | -327.48M | -311.17M | -163.15M |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - | - | - | - | -190.37M | -229.20M | -222.18M | -229.22M |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - | - | - | - | 94.45M | 352.86M | 295.69M | 117.24M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | 23.60M | -13.90M | -24.31M | -33.17M |
| Dividends Paid | - | - | - | 210.89M | 41.96M | 53.37M | 13.13M | - | - | - | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.7% | 11.8% | 12.2% | 11.5% |
| Operating Margin % | - | - | - | - | - | - | - | 7.1% | 8.2% | 8.2% | 8.7% | 10.3% | - | 3.1% | 5.5% | 5.2% | 6.2% |
| Net Margin % | - | - | - | - | - | - | - | 2.7% | 4.1% | 2.7% | 2.7% | 4.7% | - | 3.4% | 5.0% | 4.1% | 2.7% |
| ROE % | 9.9% | 9.9% | 13.2% | 20.7% | 14.5% | 16.3% | 15.2% | 14.1% | 21.5% | 17.2% | 19.3% | 24.4% | - | 14.2% | 18.9% | 12.7% | 8.6% |
| ROCE % | - | 10.6% | 13.0% | 14.1% | 12.3% | 11.2% | 7.5% | 6.9% | 7.9% | 7.9% | 7.3% | 9.1% | - | 2.2% | 4.1% | 5.8% | 6.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SEM
Merger moves 194,710 Select Medical (NYSE: SEM) shares to parent - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxQai1DeDAwSmQyTmdENjM5TVVISFdsZVEwR3g0Z29nTjQwN2l4UElBWFI4U0gzaTZwcndQU1hKRjZ0OHN4d0F2M2JoVEl3aXhVMmdyaENiZk45eU1mSlNBOGFFS2VsVW1BWDFMd2YwMEE4NVE0SGtQMkUxdGM2NGl6T1YwQ0xPd0dieUxiR2…
Select Medical (SEM) Soars 8.4%, Traders Snap up Shares Ahead of Delisting - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTFBEQ29COG5XYTBXTl9BVEZ0X3NjUW01RGtHalZ4YzA5OUhQcXQ0QTcwTnVMWEwwN0xXWU5BQ3U3NW5DTkFaOFpuRjg2OUNPSnQ3a0hObXJTZXF6Y3dFYmNzU3h6TmVXTXdGTDFSTmNsV2ZBU1k5d0YyY0M1SEE?oc=5" target="_blank">…
SELECT MEDICAL HOLDINGS CORP (SEM) Stock Chart - ChartMill
<a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTE1HMVQwUk9UTjdoOUdtNUVrZmktMENybFozeUdCenRsVmtOMmwyUkhjSi1TUWpSemUxRHdCUTNIMXJ5MHhlMFhmVERlTGNrQ0xsbVd2aHJzNXhmVXM5WlNJVFVFcw?oc=5" target="_blank">SELECT MEDICAL HOLDINGS CORP (SEM…
Select Medical Stock Jumps 8% After $16.50 Buyout Offer. Here’s What the Deal Means - TIKR.com
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQazFIcDlxUkdSN01LNGZ2dFJIeWhQTFVHVmg0eXJXNFhaWmZmQVRocnBXS3NKeFJ6WGVQOVllVHpZSDNfb2xOOGlHelFoRFEwU0FXSnM2b3lqQV9wZ0QwdmZFYi0wRmxIOUV0b1FoVU16TEcyZzQ5UTFwR3NJLWZDaDY5UTZWdl8zbVpldV…
What's Happening with Select Medical Holdings (SEM) - Kavout | AI
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxQTWs2SzdfNWd2ZVFnWkZ5VExGTTZlRHlKQzNFWmR0dm42cm5BSVZPVktRSDhOcmY3d2R6TFRzemg5Y1djblJZNXBEX2JOTzlqQkdta3c4TXNUTnotamJQQ2k3ZnJqcUh0dWx1RldWMGoySGFhMF9QanppV2h3X25HLXVLeEpVZF9fdFU3Vg…
[15-12G] SELECT MEDICAL HOLDINGS CORP SEC Filing - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQRkRGclNpRlZrR0ZldWw2SUZ5WUtDVU9ibWpYZ1hoRHRvRGRkSlpKTnRKZGRWS1hQOFpoNFVEdGs1WUNhWmpudXVWQ3VUaG9GZHNVUVFCWVZaRmZGNWx1Q1pzcHl5bEdlc1g5RGFyMk80emZuWnd3bUpxMmdwVG45WmJvNUtEYWxWeXROYX…
SEM — Frequently Asked Questions
What is the current share price of Select Medical Holdings Corp (SEM)?
As of 2026-07-14 21:23 PDT, Select Medical Holdings Corp (SEM) trades at $16.51 on NYQ. Its 52-week range is $16.51 to $16.51.
What is the market capitalisation of SEM?
Select Medical Holdings Corp (SEM) has a market capitalisation of $2.05B on NYQ.
What is the P/E ratio of SEM?
SEM trades at a trailing price-to-earnings (P/E) ratio of 15.43. The industry average P/E is 25.41. Its price-to-book (P/B) ratio is 1.17.
Does SEM pay a dividend?
Select Medical Holdings Corp (SEM) currently offers a dividend yield of 0.02%.
What is the return on equity (ROE) of SEM?
SEM has a return on equity (ROE) of 9.81%. Its return on capital employed (ROCE) is 6.91%.
Is SEM a good stock to buy?
This page provides a data-driven analysis of Select Medical Holdings Corp (SEM), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.